Trial Profile
Pharmacokinetics study of low dose efavirenz in Taiwanese patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary)
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
- 26 Dec 2015 New trial record